Health

Verato CEO Mark LaRow to Participate in ONC Webinar on Patient Identity and Matching

Friday, May 29, 2020 - 10:29pm

On Monday, June 1, Verato CEO Mark LaRow will present during a working session hosted by The Office of the National Coordinator for Health Information Technology (ONC) on patient identity and matching.

Key Points: 
  • On Monday, June 1, Verato CEO Mark LaRow will present during a working session hosted by The Office of the National Coordinator for Health Information Technology (ONC) on patient identity and matching.
  • Verato is the next generation of EMPI and patient matching.
  • Verato sets the standard for fast-to-implement and high-accuracy identity matching through our cloud-based services.
  • As a HITRUST-certified EMPI, over 50 of the nations most innovative healthcare organizations rely on Verato Referential Matching to manage and link person data quickly and at scale.

Molina Healthcare Reaffirms its Commitment to Kentucky

Friday, May 29, 2020 - 10:27pm

Molina Healthcare is excited to reaffirm its commitment to the Commonwealth of Kentucky and to the city of Louisville with todays announcement of its upcoming participation in Kentuckys Medicaid managed care program.

Key Points: 
  • Molina Healthcare is excited to reaffirm its commitment to the Commonwealth of Kentucky and to the city of Louisville with todays announcement of its upcoming participation in Kentuckys Medicaid managed care program.
  • Our team at Molina is ready to begin serving the Commonwealth of Kentucky, said Molinas president and chief executive officer, Joe Zubretsky.
  • Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces.
  • Through its locally operated health plans, Molina Healthcare served approximately 3.4 million members as of March 31, 2020.

Global Alcohol Prep Pads Market 2020-2024 | Evolving Opportunities with Avantor Inc. and B. Braun Melsungen AG | Technavio

Friday, May 29, 2020 - 10:30pm

The global alcohol prep pads market is expected to grow by USD 160.61 million as per Technavio.

Key Points: 
  • The global alcohol prep pads market is expected to grow by USD 160.61 million as per Technavio.
  • In addition, the increasing availability of online retailers is anticipated to boost the growth of the alcohol prep pads market.
  • The rise in the number of surgical procedures worldwide has increased the demand for surgical accessories, including alcohol prep pads.
  • B. Braun Melsungen AG operates its business through segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.

FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women

Friday, May 29, 2020 - 9:14pm

"This approval provides women with a non-surgical option to help address unresolved heavy menstrual bleeding in an impactful way."

Key Points: 
  • "This approval provides women with a non-surgical option to help address unresolved heavy menstrual bleeding in an impactful way."
  • "ORIAHNN signifies an important advance in how we can care for women with uterine fibroids."
  • "The FDA's approval of an oral treatment for women suffering from heavy menstrual bleeding due to uterine fibroids marks a step forward in women's health.
  • ORIAHNN can decrease your menstrual bleeding or result in no menstrual bleeding at all, making it hard to know if you are pregnant.

The Association of Dental Support Organizations (ADSO) Applauds Northeast Insurance Dental Companies for PPE Support During COVID-19

Friday, May 29, 2020 - 9:02pm

ARLINGTON, Va., May 29, 2020 /PRNewswire/ -- The Association of Dental Support Organizations (ADSO), its members and supported dental practices thank and applaud Northeast Delta Dental, Delta Dental of Connecticut, Delta Dental of New Jersey, Principal, Unum and United Concordia for their recognition and appreciation of the added burden the increased use of personal protective equipment (PPE) during the COVID-19 pandemic has caused dental offices, by providing reimbursement for these services.

Key Points: 
  • ARLINGTON, Va., May 29, 2020 /PRNewswire/ -- The Association of Dental Support Organizations (ADSO), its members and supported dental practices thank and applaud Northeast Delta Dental, Delta Dental of Connecticut, Delta Dental of New Jersey, Principal, Unum and United Concordia for their recognition and appreciation of the added burden the increased use of personal protective equipment (PPE) during the COVID-19 pandemic has caused dental offices, by providing reimbursement for these services.
  • ADSO's members and their supported dental practices will continue to provide the safest possible dental visit to the patients they serve.
  • Members of the media should email general inquiries to press@theadso.org for a response from the organization's agency of record.
  • The Association of Dental Support Organizations (ADSO) is a non-profit international trade association whose members support more than 13,000 dentists worldwide.

Molina Healthcare Wins Kentucky Medicaid Contract

Friday, May 29, 2020 - 9:54pm

Molina Healthcare, Inc. (NYSE: MOH) today announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10, 2020 by the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicaid Services (DMS).

Key Points: 
  • Molina Healthcare, Inc. (NYSE: MOH) today announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10, 2020 by the Kentucky Cabinet for Health and Family Services (CHFS), Department for Medicaid Services (DMS).
  • The new contract for Molinas Kentucky health plan is expected to begin on January 1, 2021.
  • We are honored that Kentucky CHFS has selected Molina to serve the Commonwealths most vulnerable citizens, said Joe Zubretsky, Molinas president and CEO.
  • Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces.

Moderna Announces First Participants in Each Age Cohort Dosed in Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Friday, May 29, 2020 - 9:52pm

Each participant will be assigned to receive placebo, a 50 g or a 100 g dose at both vaccinations.

Key Points: 
  • Each participant will be assigned to receive placebo, a 50 g or a 100 g dose at both vaccinations.
  • Moderna anticipates collaborating with NIAID to implement the Phase 3 study.
  • The first participant in the NIAID-led Phase 1 study of mRNA-1273 was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing.
  • Modernas investigational Zika vaccine (mRNA-1893), currently in a Phase 1 study, was granted FDA Fast Track designation in August 2019.

U. S. Steel Releases 2019 Sustainability Report

Friday, May 29, 2020 - 9:38pm

United States Steel Corporation (NYSE:X) today released its 2019 Sustainability Report, detailing its accomplishments in Environmental, Social and Governance (ESG) issues of importance to the company and its stakeholders.

Key Points: 
  • United States Steel Corporation (NYSE:X) today released its 2019 Sustainability Report, detailing its accomplishments in Environmental, Social and Governance (ESG) issues of importance to the company and its stakeholders.
  • ESG and sustainability-focused initiatives are top priorities for our company, said U. S. Steel President and Chief Executive Officer David B. Burritt.
  • This report is an important feature of our resolve to address the areas that matter most to our stakeholders.
  • United States Steel Corporation, headquartered in Pittsburgh, Pa., is a leading integrated steel producer and Fortune 250 company with major operations in the United States and Central Europe.

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

Friday, May 29, 2020 - 9:05pm

The link to the live webcast and archive will be accessible on Tandem Diabetes Cares Investor Center website located at http://investor.tandemdiabetes.com in the Events & Presentations section.

Key Points: 
  • The link to the live webcast and archive will be accessible on Tandem Diabetes Cares Investor Center website located at http://investor.tandemdiabetes.com in the Events & Presentations section.
  • Tandem Diabetes Care, Inc. ( www.tandemdiabetes.com ) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience.
  • Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.
  • Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.

Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer

Friday, May 29, 2020 - 9:15pm

Since its initial approval in 2015, IBRANCE has helped change the treatment landscape for people with HR+, HER2- metastatic breast cancer.

Key Points: 
  • Since its initial approval in 2015, IBRANCE has helped change the treatment landscape for people with HR+, HER2- metastatic breast cancer.
  • When available, the full results from the PALLAS study will be shared with the scientific community at a later date.
  • Palbociclib is also being studied in patients with high-risk early breast cancer and results from the collaborative PENELOPE-B trial are expected later this year.
  • In PALOMA-3, Grade 3 (55%) or Grade 4 (11%) decreased neutrophil counts were reported in patients receiving IBRANCE plus fulvestrant.